The present invention relates to a novel family of kinases inhibitors. Compounds of this class have been found to have inhibitory activity against members of the TEC kinase family, particularly BTK. The present invention is directed to a compound of Formula I or pharmaceutically acceptable salt, solvate, solvate of salt, stereoisomer, tautomer, isotope, prodrug, complex or biologically active metabolite thereof, for use in therapy.
这项发明涉及一类新型激酶
抑制剂。已发现该类化合物对
TEC激酶家族成员,特别是BTK,具有抑制活性。本发明涉及一种具有式I的化合物或药用可接受的盐、溶剂化合物、盐的溶剂化合物、立体异构体、互变异构体、同位素、前药、复合物或其
生物活性代谢物,用于治疗。